Obesity

SAN DIEGO — Higher amounts of visceral and subcutaneous adipose tissue are associated with an increased risk for breast cancer among postmenopausal women, according to a presenter at ObesityWeek 2022.

SAN DIEGO — Infants exposed to gestational diabetes who breastfeed for less than 6 months and drink sugar-sweetened beverages or natural fruit juice are more likely to have obesity during childhood, according to a presenter.

SAN DIEGO — Adolescents with overweight or obesity may have different degrees of weight gain during adulthood based on their obesity phenotype, according to findings presented at ObesityWeek 2022.

SAN DIEGO — Adolescents with obesity had a BMI reduction of 16.1% at 68 weeks with once-weekly subcutaneous semaglutide 2.4 mg plus lifestyle intervention, results similar to those seen with adults, according to top-line results presented at ObesityWeek 2022.

The FDA has granted breakthrough therapy designation to setmelanotide for patients with hypothalamic obesity, according to a company press release.

SAN DIEGO — Multiple new anti-obesity medications currently in the pipeline could expand treatment options for the disease in the coming years, according to a speaker at ObesityWeek 2022.

For patients with obesity, physicians should first treat excess weight when addressing underlying cardiometabolic disease, according to a speaker at the Cardiometabolic Health Congress.

ObesityWeek will be held Nov. 1 to 4 in San Diego, with a broad theme of eradicating treatment barriers in endocrinology.

Phenomix Sciences has launched their Phenomix Sciences Obesity Platform, a set of data and tools that personalize obesity treatments.

In response to controversial study data on the efficacy of colonoscopies, Nadeem Baig, MD, stressed that they are effective at saving lives when performed.